Journal of Pancreatology (Mar 2021)

The Chinese guidelines for the diagnosis and treatment of pancreatic neuroendocrine neoplasms (2020)

  • Wenming Wu,
  • Jie Chen,
  • Chunmei Bai,
  • Yihebali Chi,
  • Yiqi Du,
  • Shiting Feng,
  • Li Huo,
  • Yuxin Jiang,
  • Jingnan Li,
  • Wenhui Lou,
  • Jie Luo,
  • Chenghao Shao,
  • Lin Shen,
  • Feng Wang,
  • Liwei Wang,
  • Ou Wang,
  • Yu Wang,
  • Huanwen Wu,
  • Xiaoping Xing,
  • Jianming Xu,
  • Huadan Xue,
  • Ling Xue,
  • Yang Yang,
  • Xianjun Yu,
  • Chunhui Yuan,
  • Hong Zhao,
  • Xiongzeng Zhu,
  • Yupei Zhao,
  • on behalf of the Chinese Pancreatic Surgery Association

DOI
https://doi.org/10.1097/JP9.0000000000000064
Journal volume & issue
Vol. 4, no. 1
pp. 1 – 17

Abstract

Read online

Abstract. Pancreatic neuroendocrine neoplasms (pNENs) are highly heterogeneous, and the management of pNENs patients can be intractable. To address this challenge, an expert committee was established on behalf of the Chinese Pancreatic Surgery Association, which consisted of surgical oncologists, gastroenterologists, medical oncologists, endocrinologists, radiologists, pathologists, and nuclear medicine specialists. By reviewing the important issues regarding the diagnosis and treatment of pNENs, the committee concluded evidence-based statements and recommendations in this article, in order to further improve the management of pNENs patients in China.